ICD-10-CM Billable Code

E66.2

Morbid (severe) obesity with alveolar hypoventilation

Clinical Classification Guidelines

Inclusion Terms

  • Obesity hypoventilation syndrome (OHS)
  • Pickwickian syndrome

Medical Intelligence & Overview

Morbid obesity with alveolar hypoventilation, also known as Obesity Hypoventilation Syndrome (OHS) or Pickwickian syndrome, is a condition where excessive body weight is accompanied by inadequate breathing during sleep. This results in elevated carbon dioxide levels and decreased oxygen in the blood, which can impact overall health. The condition is characterized by severe obesity — typically a body mass index (BMI) of 40 or higher — combined with reduced ventilation efficiency. Recognizing the signs and understanding the causes can help in managing this complex health issue effectively.

Causes & Symptoms

Clinical Causes: Severe weight gain leading to excess fat accumulation around the chest and abdomen, which impairs lung expansion and airflow. Obesity-related alterations in the brain's control of breathing, resulting in decreased sensitivity to high carbon dioxide and low oxygen levels. Obstructive sleep apnea, often associated with obesity, which can further contribute to hypoventilation. Potential genetic or metabolic factors that predispose individuals to impaired respiratory regulation.

Key Symptoms: Daytime fatigue and excessive sleepiness Loud snoring and episodes of apnea during sleep Shortness of breath, especially when lying down or during exertion Morning headaches due to elevated carbon dioxide levels overnight Reduced concentration and cognitive difficulties Rapid breathing or breathlessness during activity Unexplained weight gain or difficulty losing weight despite efforts

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including measuring body mass index (BMI), sleep studies (polysomnography) to detect sleep apnea, and blood tests to evaluate blood gases. Elevated carbon dioxide levels (hypercapnia) and low oxygen levels (hypoxemia) are key indicators. Imaging studies, such as chest X-rays or lung function tests, may be used to assess lung health. The diagnosis of OHS is confirmed when severe obesity is present along with evidence of hypoventilation, after ruling out other respiratory or neurological conditions.

Treatment Protocols: Managing morbid obesity with alveolar hypoventilation requires an integrated approach, often involving healthcare specialists. Common strategies include: - Weight loss interventions, such as supervised diet plans, behavioral therapy, and, in some cases, surgical options like bariatric surgery. - Continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) therapy during sleep to improve ventilation and reduce apnea episodes. - Oxygen therapy in cases with significant hypoxemia. - Treating associated conditions like sleep apnea and hypertension. - Regular monitoring of blood gases and lung function to assess treatment effectiveness. - Lifestyle modifications, including smoking cessation, regular exercise, and healthy eating habits. Early intervention can significantly improve quality of life and reduce the risk of complications associated with this condition.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E66.2 a billable ICD-10 code?
Yes, E66.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E66.2?
Clinical documentation must specify the nature of Morbid (severe) obesity with alveolar hypoventilation and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

alveolar obesity hypoventilation morbid